| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ALUMIS INC. | President, CEO and Chairman, Director | Common Stock | 106K | $475K | $4.46 | Jul 29, 2025 | By Trust |
| ALUMIS INC. | President, CEO and Chairman, Director | Common Stock | 3K | $13.4K | $4.46 | Jul 29, 2025 | Direct |
| ALUMIS INC. | President, CEO and Chairman, Director | Stock Option (Right to Buy) | 150K | Jul 29, 2025 | Direct | ||
| Prelude Therapeutics Inc | Director | Director Stock Option (Right to Buy) | 38K | Jun 12, 2025 | Direct | ||
| Neoleukin Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25K | Jun 8, 2023 | Direct | ||
| 89bio, Inc. | Director | Stock Option (Right to Buy) | 0 | Oct 30, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ETNB | 89bio, Inc. | Oct 30, 2025 | 2 | $0 | 4 | Oct 30, 2025 | Director |
| ALMS | ALUMIS INC. | Jul 29, 2025 | 2 | $0 | 4 | Jul 31, 2025 | President, CEO and Chairman, Director |
| PRLD | Prelude Therapeutics Inc | Jun 12, 2025 | 1 | $0 | 4 | Jun 13, 2025 | Director |
| ALMS | ALUMIS INC. | Apr 1, 2025 | 1 | $101K | 4 | Apr 3, 2025 | President, CEO and Chairman, Director |
| ALMS | ALUMIS INC. | Feb 18, 2025 | 1 | $0 | 4 | Feb 20, 2025 | President, CEO and Chairman, Director |
| ETNB | 89bio, Inc. | Feb 3, 2025 | 1 | $0 | 4 | Feb 5, 2025 | Director |
| ALMS | ALUMIS INC. | Jun 27, 2024 | 21 | $0 | 4 | Jul 1, 2024 | President, CEO and Chairman, Director |
| ALMS | ALUMIS INC. | Jun 27, 2024 | 0 | $0 | 3 | Jun 27, 2024 | President, CEO and Chairman, Director |
| PRLD | Prelude Therapeutics Inc | Jun 14, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
| ETNB | 89bio, Inc. | May 2, 2024 | 1 | $0 | 4 | May 3, 2024 | Director |
| ETNB | 89bio, Inc. | Apr 13, 2024 | 0 | $0 | 3 | Apr 23, 2024 | Director |
| PRLD | Prelude Therapeutics Inc | Jun 16, 2023 | 1 | $0 | 4 | Jun 21, 2023 | Director |
| NLTX | Neoleukin Therapeutics, Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
| PRLD | Prelude Therapeutics Inc | Jun 17, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
| NLTX | Neoleukin Therapeutics, Inc. | May 12, 2022 | 1 | $0 | 4 | May 16, 2022 | Director |
| PRLD | Prelude Therapeutics Inc | Jul 19, 2021 | 1 | $0 | 4 | Jul 20, 2021 | Director |
| PRLD | Prelude Therapeutics Inc | Jul 19, 2021 | 0 | $0 | 3 | Jul 20, 2021 | Director |
| NLTX | Neoleukin Therapeutics, Inc. | May 11, 2021 | 1 | $0 | 4 | May 13, 2021 | Director |